本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Kalvista Pharmaceuticals Inc

13.41
+0.33002.52%
成交量:26.05萬
成交額:346.79萬
市值:6.67億
市盈率:-3.60
高:13.55
開:13.00
低:12.90
收:13.08
資料載入中...
2024/09/05

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/07/23

重要事件披露

Form 8-K - Current report
2024/07/17

SEC問詢函

Form CORRESP - Correspondence
2024/07/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/11

重要事件披露

Form 8-K - Current report
2024/07/11

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/06/28

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/04/22

重要事件披露

Form 8-K - Current report
2024/04/02

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/03/11

重要事件披露

Form 8-K - Current report
2024/03/11

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/03/07

重要事件披露

Form 8-K - Current report
2024/02/26

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/22

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/02/20

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/02/16

重要事件披露

Form 8-K - Current report
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

重要事件披露

Form 8-K - Current report
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]